Donald Trump explained during the unveiling of Robert F. Kennedy Jr.’s “Make America Healthy Again” report Thursday that his ...

At least six organizations that claim to champion patient rights have deep financial and operational ties to Big Pharma and ...

The president announced last week that his administration would be instituting a “most favored nation” policy that would peg ...

The U.S. Department of Health and Human Services said on Tuesday it would set drug prices pegged to the lowest level paid by ...

President Donald Trump signed an executive order Monday aiming to significantly reduce prescription drug prices in the United ...

This month, the Centers for Medicare and Medicaid Services will begin meeting with patients who use the 15 drugs it selected ...

Currently, Medicare has to wait seven years after a traditional drug gets approved by the U.S. Food and Drug Administration ...

The new guidance builds on previous years’ by increasing the focus on transparency and expanding, per statute, to include ...

The executive order directs Trump's administration to take actions against "discriminatory" policies in foreign countries ...

The Trump administration is already gearing up for another round of Medicare drug price negotiations, while OpenAI launched a ...

Under the Medicare Drug Price Negotiation Program, the HHS secretary negotiates directly with manufacturers on the prices Medicare will pay for pharmaceuticals.

Conflicting QSSD definitions from two federal agencies mean that CMS’ administrative authority on drug pricing and payment is ...